3Wahren J. C-peptide : new findings and therapeutic implications in diabetes[ J]. Clin Physiol Funct Imaging,2004,24(4) : 180-189.
4Begue P, Coste T C, Jannot M F, et al. C-peptide Na^+ -K^+ -ATPase and diabetes [ J ]. Experimental Diab Res,2004,5 : 37-50.
5John Wahren.C -peptide:new findings and therapeutic implications in diabetes[J].Clinical Physiology and Functional Imaging,2004,24(4):180-189.
6Kunt T,Schneider S,Pfützner A,et al.The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus[J].Diabetologia,1999,42(4):465-471.
7Tsimaratos M,Roger F,Chabardes D,et al.C -peptide stimulates Na^+-K^+-ATPase activity via PKC alpha in rat medullary thick ascending limb[J].Diabetologia,2003,46(1):124-131.
9Daniela M,Emilia R,Angela Marie A,et al.Residual C-peptide secretion and endothelial function in patients with type2 diabetes[J].Clinical Science,2003,105:113-118.
10De La Tour DD,Raccah D,Jannot MF,et al.Erythrocyte Na^+-K^+-ATPase activity and diabetes:relationship with Cpeptide level[J].Diabetologia,1998,41:1080-1084.
5Sapin R. Insulin assays : previously known and new analyt-ical features[J].Clin Lab, 2003,49 (3/4) : 113-121.
6Karabulut A,Iltumur K,Toprak Net al. Insulin response to oral ~ueose loading and coronary artery disease in nondiabetics[J].Int Heart J,2005,46(5) :761.
7Wahren A,Jornvall H. C-peptide makes a comeback [J].Diabe- tes Metab Res Rev,2003,19(5):345.
